- A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy
Zehao Zheng et al, 2024, Cancer Immunol Immunother CrossRef - Fasting Blood Glucose-Based Novel Predictors in Detecting Metastases and Predicting Prognosis for Patients with PNENs
Li Yu et al, 2024, JPM CrossRef - Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo et al, 2024, Journal of Hepatology CrossRef